Welcoming Rivet to the Portfolio

Welcoming Rivet to the Portfolio

We are pleased to announce that we recently led a $20.5 million Series B in Rivet, a company on a mission to solve the broken healthcare billing process. Rivet provides a healthcare billing platform that promotes transparency around pricing and financial responsibility across the key stakeholders in healthcare – patients, providers and payers. The company is led by a trio of first-time co-founders in Ted Ferrin, Andrew Harding and Paul Draper who possess a keen ability to identify an acute problem in the market, develop and launch a product and achieve product-market fit in rapid succession.

Rivet Raises $20.5 Million Series B Led by Catalyst Investors

Rivet, the modern healthcare billing platform, raised $20.5 million in a Series B funding round led by Catalyst Investors with participation from co-investor Ankona Capital and existing investors Menlo Ventures, Pelion Venture Partners and Lux Capital. Catalyst’s Tyler Newton will join Rivet’s Board of Directors.